DOI:
10.1055/s-00000058
Planta Medica
LinksClose Window
References
Jung JI, Chung E, Seon MR, Shin HK, Kim EJ, Lim SS, Chung WY, Park KK, Park JH.
Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells.
Biofactors 2006;
28: 159-168
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.